Results 141 to 150 of about 15,262 (256)

The DeepJoint Algorithm: An Innovative Approach for Studying the Longitudinal Evolution of Quantitative Mammographic Density and Its Association With Screen‐Detected Breast Cancer Risk

open access: yesBiometrical Journal, Volume 68, Issue 3, June 2026.
ABSTRACT High mammographic density is a well‐known risk factor for breast cancer and reduces the sensitivity of mammography‐based screening. While automated machine and deep learning‐based methods provide more consistent and precise measurements compared to subjective Breast Imaging Reporting and Data System (BI‐RADS) assessments, they often fail to ...
Manel Rakez   +7 more
wiley   +1 more source

Rationale and Trial Design of DAWNA‐FES Trial: Single‐Arm Phase II Study of Endocrine Therapy With Dalpiciclib After Progression on CDK4/6 Inhibition Based on [18F]FES PET/CT in Patients With HR+/HER2− Advanced Breast Cancer

open access: yesCancer Innovation, Volume 5, Issue 3, June 2026.
The DAWNA‐FES trial is a prospective, single‐center, single‐arm phase II study evaluating dalpiciclib plus endocrine therapy in patients with HR+/HER2− advanced breast cancer who have progressed on prior CDK4/6 inhibitors and have at least one [18F]FES‐positive lesion.
Ru Yao   +12 more
wiley   +1 more source

Food and Nutrition Insecurity in Cancer Survivorship: A Global Scoping Review

open access: yesCancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Background This scoping review maps and synthesises existing literature on food and nutrition insecurity (FNI) among cancer survivors and carers, many of whom experience physical, psychosocial, practical and financial burdens, coupled with increased nutritional requirements from cancer and its treatment.
Susannah K. Ayre   +6 more
wiley   +1 more source

Burnout and work-life balance: the generational points of view. [PDF]

open access: yesInsights Imaging
Molwitz I   +4 more
europepmc   +1 more source

Blood‐based cell‐free DNA and multitarget stool RNA screening tests to detect colorectal cancer: A systematic review

open access: yesCancer, Volume 132, Issue 11, 1 June 2026.
Abstract Two new tests, a cell‐free DNA (cfDNA) blood‐based test (BBT) and multitarget stool RNA (mt‐sRNA) test with in‐laboratory fecal immunochemical testing, were recently approved by the US Food and Drug Administration, and a second BBT is under review. These tests have the potential to overcome barriers to screening.
Karli K. Kondo   +4 more
wiley   +1 more source

Current challenges and the way forwards for regulatory databases of artificial intelligence as a medical device. [PDF]

open access: yesNPJ Digit Med
Ong AY   +8 more
europepmc   +1 more source

Regulation of Immune Checkpoints: From Molecular Mechanisms to Clinical Therapies

open access: yesMedComm, Volume 7, Issue 6, June 2026.
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by unleashing antitumor immunity. This review comprehensively examines the molecular mechanisms underlying key immune checkpoints—including PD‐1/PD‐L1, CTLA‐4, and TIM‐3—and their clinical applications.
Qintao Ge   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy